Long-Term Effectiveness and Cost-Effectiveness of Metformin Combined with Liraglutide or Exenatide for Type 2 Diabetes Mellitus Based on the CORE Diabetes Model Study

BACKGROUND: Type 2 diabetes mellitus (T2DM) is associated with β cell impairment. Agonists of the glucagon-like peptide 1 (GLP-1) receptor (such as liraglutide and exenatide) can increase the number of pancreatic β cells and improve cell function. These drugs contribute to the long-term control of T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuesong, Liu, Sisi, Li, Yukun, Wang, Yan, Tian, Meimei, Liu, Guoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909290/
https://www.ncbi.nlm.nih.gov/pubmed/27304904
http://dx.doi.org/10.1371/journal.pone.0156393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909290/
https://www.ncbi.nlm.nih.gov/pubmed/27304904
http://dx.doi.org/10.1371/journal.pone.0156393

Ejemplares similares